Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine
Woo W, Kim A, Yon D, Lee S, Hwang J, Jacob L, Koyanagi A, Kim M, Moon D, Jung J, Choi J, Jung S, Eun L, Lee S, Shin J, Smith L. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine. Journal Of Medical Virology 2021, 94: 1566-1580. PMID: 34862617, PMCID: PMC9015469, DOI: 10.1002/jmv.27501.Peer-Reviewed Original ResearchConceptsGastrointestinal symptomsMRNA-1273Conservative careIntensive careAnalyzed clinical manifestationsMRNA COVID-19 vaccineLeft ventricular dysfunctionProportion of patientsMRNA-1273 vaccineOutcome of myocarditisIntensive care unitInvestigate risk factorsMagnetic resonance imagingRisk factor analysisMRNA-1273 recipientsPrognostic factorsVentricular dysfunctionClinical courseEjection fractionMedian ageClinical presentationMyocardial inflammationCase seriesClinical characteristicsCase report
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply